Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Jeuveau (prabotulinumtoxinA-xvfs) - AEON Biopharma

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines (clinicaltrials.gov) - May 15, 2026 - P=N/A | N=756 | Completed | Sponsor: Evolus, Inc. | Active, not recruiting ➔ Completed
Trial completion

http://clinicaltrials.gov/ct2/show/NCT05481931

May 15, 2026